Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
78pct
60d open
vs 5,821 other HR bills in the 113th — cohort avg 49d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2014 · third_quarter · Pharmacy
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $120,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · first_quarter · Copyright/Patent/Trademark
Intellectual Property and Process Patent Issues - HR 1908 Patent Reform Act (all provisions, Cyber security, Transpacific partnership
Client expense: $926,490 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Pharmacy
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Client expense: Not reported · Firm income: $105,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · first_quarter · Copyright/Patent/Trademark
Intellectual Property and Process Patent Issues - HR 1908 Patent Reform Act (all provisions, Cyber security, Transpacific partnership
Client expense: $1,152,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · first_quarter · Copyright/Patent/Trademark
Intellectual Property and Process Patent Issues - H.R. 1908, Patent Reform Act (all provisions).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · first_quarter · Pharmacy
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Client expense: Not reported · Firm income: $105,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Copyright/Patent/Trademark
Intellectual Property and Process Patent Issues - H.R. 1908, Patent Reform Act (all provisions).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Pharmacy
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Pharmacy
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Client expense: Not reported · Firm income: $105,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Copyright/Patent/Trademark
Intellectual Property and Process Patent Issues - H.R. 1908, Patent Reform Act (all provisions).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Pharmacy
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Client expense: Not reported · Firm income: $105,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Copyright/Patent/Trademark
Issues related to Intellectual Property and Process Patent Issues - HR 1908, Patent Reform Act (all provisions); Implementation of P.L. 108-173, matters related to Medicare and Medicaid Coverage and Reimbursement [Medicare Prescription Drug Act of 2003]; issues relating to Prescription Drug User Fee Act and ASP +6; issues re: comparative effectiveness and followon biologics; FDA repeal of Avastin; coverage of Lucentis & Avastin; trade issues; & HR 942- American Research & Competiveness Act of 2011.
Client expense: Not reported · Firm income: Not reported
2013 · third_quarter · Medicare/Medicaid
Issues related to Intellectual Property and Process Patent Issues - HR 1908, Patent Reform Act (all provisions); Implementation of P.L. 108-173, matters related to Medicare and Medicaid Coverage and Reimbursement [Medicare Prescription Drug Act of 2003]; issues relating to Prescription Drug User Fee Act and ASP +6; issues re: comparative effectiveness and followon biologics; FDA repeal of Avastin; coverage of Lucentis & Avastin; trade issues; & HR 942- American Research & Competiveness Act of 2011.
Client expense: Not reported · Firm income: Not reported
2013 · third_quarter · Trade (domestic/foreign)
Issues related to Intellectual Property and Process Patent Issues - HR 1908, Patent Reform Act (all provisions); Implementation of P.L. 108-173, matters related to Medicare and Medicaid Coverage and Reimbursement [Medicare Prescription Drug Act of 2003]; issues relating to Prescription Drug User Fee Act and ASP +6; issues re: comparative effectiveness and followon biologics; FDA repeal of Avastin; coverage of Lucentis & Avastin; trade issues; & HR 942- American Research & Competiveness Act of 2011.
Client expense: Not reported · Firm income: Not reported
2013 · second_quarter · Medicare/Medicaid
HR1404 "Medicaid Expansion Repeal and State Flexibility Act," all provisions. HR 1908 "Federal Repeal of Expensive Exchanges Act," all provisions. S963 "Preventing an Unrealistic FMAP Act," all provisions. Issues relating to Medicare Structural Reform including means testing, raising the retirement age, and the physician payment formula. Issues relating to Medicaid expansion and health care exchanges, including repeal of the match rate and fiscal implications of these provisions.
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · second_quarter · Health Issues
HR1549 "Helping Sick Americans Now Act," all provisions. HR1908 "Federal Repeal of Expensive Exchanges Act," all provisions. Issues relating to legislation to repeal or delay cost provisions of the Affordable Care Act, including its connection to an increase in the debt ceiling. Issues relating to potential legislation addressing High Risk Pools. Issues relating to IRS Federal Exchange regulations. Issues relating to health care reform including the tax treatment of health care and reforms meant to hold down costs.
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · second_quarter · Pharmacy
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Client expense: Not reported · Firm income: $98,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · second_quarter · Pharmacy
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Client expense: Not reported · Firm income: $105,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · first_quarter · Copyright/Patent/Trademark
Intellectual Property and Process Patent Issues- HR 1908, Patent Reform Act (all provisions).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · first_quarter · Pharmacy
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Client expense: Not reported · Firm income: $98,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · first_quarter · Pharmacy
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Client expense: Not reported · Firm income: $105,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| UT |
| Cynthia M. Lummis | Republican | WY |
| David P. Roe | Republican | TN |
| David Schweikert | Republican | AZ |
| Doug Collins | Republican | GA |
| Doug LaMalfa | Republican | CA |
| Doug Lamborn | Republican | CO |
| Eric A. "Rick" Crawford | Republican | AR |
| Jack Kingston | Republican | GA |
| Jeb Hensarling | Republican | TX |
| Jeff Denham | Republican | CA |
| Jeff Duncan | Republican | SC |
| Jeff Miller | Republican | FL |
| Jim Bridenstine | Republican | OK |
| Jim Jordan | Republican | OH |
| Justin Amash | Libertarian | MI |
| Louie Gohmert | Republican | TX |
| Luke Messer | Republican | IN |
| Mark Meadows | Republican | NC |
| Michele Bachmann | Republican | MN |
| Mo Brooks | Republican | AL |
| Paul A. Gosar | Republican | AZ |
| Paul C. Broun | Republican | GA |
| Randy K. Weber, Sr. | Republican | TX |
| Randy Neugebauer | Republican | TX |
| Raúl R. Labrador | Republican | ID |
| Richard Hudson | Republican | NC |
| Rob Bishop | Republican | UT |
| Robert Pittenger | Republican | NC |
| Rodney Davis | Republican | IL |
| Ron DeSantis | Republican | FL |
| Stevan Pearce | Republican | NM |
| Steve Chabot | Republican | OH |
| Steve Scalise | Republican | LA |
| Steve Stockman | Republican | TX |
| Ted Poe | Republican | TX |
| Ted S. Yoho | Republican | FL |
| Thomas Massie | Republican | KY |
| Tim Huelskamp | Republican | KS |
| Tim Walberg | Republican | MI |
| Todd Rokita | Republican | IN |
| Tom McClintock | Republican | CA |
| Trent Franks | Republican | AZ |
| Trey Radel | Republican | FL |
| Walter B. Jones | Republican | NC |